Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hospice × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 140 Lymphoma 35 Leukemia 35 Leukemia, Lymphocytic, Chronic, B-Cell 34 Multiple Myeloma 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Neoplasms, Plasma Cell 31 Lymphoma, Non-Hodgkin 30 Lymphoma, Mantle-Cell 30 Lymphoma, Large-Cell, Immunoblastic 30 Lymphoma, Large B-Cell, Diffuse 30 Lymphoma, Follicular 30 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 29 Monoclonal Gammopathy of Undetermined Significance 29 Burkitt Lymphoma 29 Lymphoma, B-Cell, Marginal Zone 28 Leukemia, Myeloid, Acute 28 Hodgkin Disease 28 Myeloproliferative Disorders 27 Myelodysplastic Syndromes 27 Immunoblastic Lymphadenopathy 27 Primary Myelofibrosis 26 Lymphoma, Large-Cell, Anaplastic 26 Thrombocythemia, Essential 25 Lymphoma, T-Cell, Cutaneous 25 Immunoglobulin Light-chain Amyloidosis 25 Waldenstrom Macroglobulinemia 24 Leukemia, Myeloid, Chronic-Phase 24 Leukemia, Biphenotypic, Acute 24 Leukemia, Prolymphocytic 23

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡